BioSkryb is a venture-backed startup bringing new solutions for cellular heterogeneity, in both the research and clinical space studies, using a proprietary genome amplification system.
Location: United States, North Carolina, Durham
Phone: +1 919-370-0841
Total raised: $11.5M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Anzu Partn... | anzupartne... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.01.2020 | Seed | $11.5M | - |
Mentions in press and media 9
| Date | Title | Description |
| 04.08.2023 | BioSkryb Genomics to Bring High-Throughput Automation to Single-Cell Genomics | The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy BioSkryb Genomics, a pioneer... |
| 02.08.2023 | Whole Genome Amplification: Studying Tissue Mosaicism and Evolution with Primary Template-Directed Amplification, Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars The webinar will also detail methods for integrating PTA with whole transcriptome sequencing from the same cells. TORONTO (PRWEB) August 02, 2023 Explore the cutting edge of genomic research in an upcoming webin... |
| 02.07.2021 | CureVac gains COO and hands Florian von der Mülbe new assignment in the midst of Covid-19 vaccine troubles; As Ken Frazier retires, Merck hires chief strategy officer | Malte Greune → Aiming to bounce back and trying to accentuate the positive after its mRNA Covid-19 vaccine took a major pratfall, CureVac is shaking things up by bringing in Malte Greune as COO and giving new responsibi... |
| 22.01.2020 | Industrial technologies get a big backer with Anzu Partners’ new $190 million fund | Advances in biology, biochemistry, sensors and automation have the potential to reshape the ways manufacturing in America is done, and a relatively new firm called Anzu Partners has just raised $190 million to invest in companies turning th... |
| 16.01.2020 | Genomic Amplification Company BioSkryb Secures $11.5 Million | BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, announced it raised $11.5 million in funding BioSkryb — a developer of genomic amplification technologies that delive... |
| 09.01.2020 | Daily funding roundup - January 9th, 2020 | Sea Star Beachwear raised $1.2M; Docket landed $1.5M; Finnomena secured $10M Sea Star Beachwear: Sea Star Beachwear creates water-friendly espadrille made partly of neoprene. Sea Star Beachwear has raised $1.25 million in seed funding from ... |
| 09.01.2020 | Single Cell Genome Sequencing Company BioSkryb Raises $11.5M in Seed Funding Round | We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT |
| 09.01.2020 | BioSkryb Raises $11.5M in Seed Funding | BioSkryb, a Durham, N.C.-based single cell genome sequencing company, raised $11.5M in seed funding. The round was led by Anzu Partners with participation from law firm Wilson Sonsini Goodrich & Rosati. The company intends to use the fu... |
| 09.01.2020 | BioSkryb Inks $11.5M Seed Round | DURHAM, N.C., BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. >> Click here for more funding data on... |